Equibles does not estimate personal net worth.
Get an email with a short summary when Quest Diagnostics Inc publishes a filing, an earnings call transcript or a press release.
Get DGX alertsSam Samad is recorded as CFO at Quest Diagnostics Inc (DGX). Sam Samad has spoken on 16 earnings calls and 1 other investor event across 1 company, most recently for Quest Diagnostics Inc on September 14, 2026. Quest Diagnostics Inc is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Quest Diagnostics Inc includes Mr. Davis (CEO), Sam A. Samad (CFO), Michael E. Prevoznik (General Counsel) and 7 others.
“I'm accompanied here by Brahmin Chokshi, who's our new head of investor relations. So I don't know if you've met her. She came to us from Merck. Now it's been, what, two months?”
“In the second quarter, consolidated revenues were $3.04 billion, up 10.2 percent versus the prior year. Consolidated organic revenues grew by 10 percent.”
“As Jim mentioned, our solid first quarter results reflect the disciplined execution of our strategy. Consolidated revenues were $2.9 billion, dollars, up 9.2% versus the prior year, and consolidated organic revenues grew by 9% in the quarter.”
“In the fourth quarter, consolidated revenues were $2.81 billion, up 7.1% versus the prior year. Consolidated organic revenues grew by 6.4%.”
“On PAMA, so, you know, to kind of probabilize it here or put odds on it is difficult. I would tell you, you know, the Results Act has been proposed.”
Diagnostics & Research · Healthcare
CFO
